Cutting-Edge Biomarker Discovery and Molecular Analytics: Revolutionizing Early Disease Detection

Mavaddat N, Antoniou AC, Mooij TM, Lynge E. BRCA1 and BRCA2 mutation carriers: Risk management and outcomes. Nat Rev Clin Oncol. 2020;17(5):299-309.

Punglia RS, D'Amico AV, Catalona WJ, Roehl KA. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med. 2013;349(4):335-42. Doi: https://doi.org/10.1056/NEJMoa021659 PMid:12878740

Bujak R, Struck-Lewicka W, Markuszewski MJ, Kaliszan R. Metabolomics for laboratory diagnostics. J Pharm Biomed Anal. 2015;113:108-20. Doi: https://doi.org/10.1016/j.jpba.2014.12.017 PMid:25577715

Wan JC, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, et al. Liquid biopsies come of age: Towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17(4):223-38. Doi: https://doi.org/10.1038/nrc.2017.7 PMid:28233803

Coffin JM, Hughes SH, Varmus HE. Retroviruses. Cold Spring Harbor Laboratory Press; 2018.

Aebersold R, Mann M. Mass-spectrometric exploration of proteome structure and function. Nature. 2016;537(7620):347-55. Doi: https://doi.org/10.1038/nature19949 PMid:27629641

Hernández-Romero D, Vílchez JA, Lahoz A, Jover E, Romero-Aniorte AI, García-Honrubia A, et al. High-sensitivity troponin T as a biomarker for the stratification of patients with acute heart failure. Eur J Heart Fail. 2013;15(7):789-96.

Hampel H, O'Bryant SE, Durrleman S, Younesi E, Rojkova K, Escott-Price V, et al. A Precision Medicine Initiative for Alzheimer's disease: The road ahead to biomarker-guided diagnostic, prognostic, and therapeutic strategies. Front Neurol. 2018;9:702.

Esteva A, Chou K, Yeung S, Naik N, Madani A, Mottaghi A, et al. Deep learning-enabled medical computer vision. NPJ Digit Med. 2019;2(1):1-9.